Phase 1/2 Study to Determine Optimal Dose for Treating Bone Metastases Using Novel STAT-RT Workflow
NCT02145286
·
clinicaltrials.gov ↗
NA
Phase
UNKNOWN
Status
47
Enrollment
OTHER
Sponsor class
Conditions
Metastatic Bone Lesion
Interventions
RADIATION:
Stereotactic Body Radiation Therapy
Sponsor
Paul W. Read, MD